NDC 66112-0919-02: Labetalol Hydrochloride 100 mg Tablet, Film Coated, Bottle of 100
This is a package of 100 tablets of Labetalol Hydrochloride 100 mg Tablet, Film Coated from Piramal Pharma Limited, first listed with the FDA Dec 2025 and currently FDA-listed.
NDC database record
One package, one record: these facts belong to NDC 66112-919-02 alone.
- Record
- FDA NDC Directory package listing · Drug for further processing
- Code segments
- 66112 labeler · 919 product · 02 package
- Package marketed since
- Dec 22, 2025
- Listing certified through
- Dec 31, 2026
- Barcode (UPC-A, from the NDC)
- 3 6611291902 0
- FDA record last changed
- Jul 24, 2026
Other active recalls for Labetalol Hydrochloride (different manufacturers) — 1 · tap to view
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
- RxNorm (NLM RxNav) · catalog refreshed Nov 19, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Nov 19, 2026
Clinical
- Labetalol lowers blood pressure. The tablets are used long term for high blood pressure, alone or with other medicines like water pills. The injection is used in the hospital for s...
- Tablets are taken by mouth, usually twice a day. Your prescriber will start low and adjust slowly, so follow your label closely. Food increases how much your body absorbs, so try t...
- No. Stopping a beta blocker suddenly can worsen chest pain and has led to heart attacks in some people. If you need to stop, your doctor will lower the dose gradually over 1 to 2 w...
- Labetalol blocks alpha receptors, so your blood pressure can drop more when you stand. This is most likely 2 to 4 hours after a dose, and especially when starting or raising the do...
Patient education
Drug interactions
Supplement & herbal interactions
Labetalol may be associated with lower levels of 1 nutrient — worth a chat with your pharmacist, not a cause for alarm.
Where does this data come from?
- MedlinePlus (NLM) · refreshed Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Nov 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Nov 19, 2026
- CMS Part D plan pricing files · refreshed Oct 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 66112-0919-01 66112-919-01 Main listing | 30 TABLET, FILM COATED in 1 BOTTLE | — | — | Active |
| 66112-0919-02 You're viewing this | 100 TABLET, FILM COATED in 1 BOTTLE | — | — | Active |
| 66112-0919-03 66112-919-03 | 500 TABLET, FILM COATED in 1 BOTTLE | — | — | Active |
You're viewing one of 3 pack sizes for this product.
Pack size FAQ
What quantity is in this package?
How does this package differ from NDC 66112-0919-01?
What NDC number is used to bill for this package of Labetalol Hydrochloride 100 mg Tablet, Film Coated?
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Labetalol Hydrochloride 100 mg 71247-0126-01 | Innogenix, | 100 tablets | $0.083 | AB | FDA listed | — |
| Labetalol Hydrochloride 100 mg 68382-0798-01 | Zydus | 100 tablets | $0.083 | AB | Availability likely | — |
| Labetalol Hydrochloride 100 mg 72888-0120-01 | Advagen | 100 tablets | $0.083 | AB | Availability likely | — |
| Labetalol Hydrochloride 100 mg 62135-0791-60 | Chartwell | 60 tablets | $0.083 | AB | Availability likely | — |
| Labetalol Hydrochloride 100 mg 72603-0902-01 | NorthStar | 100 tablets | $0.083 | AB | Availability likely | — |
| Labetalol Hydrochloride 100 mg 68001-0700-00 | BluePoint | 100 tablets | $0.083 | AB | Availability likely | — |
| Labetalol Hydrochloride 100 mg 29300-0252-01 | Unichem | 100 tablets | $0.083 | AB | Availability likely | — |
| Labetalol Hydrochloride 100 mg 00904-7451-61 | Major | 1 tablet | $0.083 | AB | Availability likely | — |
| Labetalol Hydrochloride 100 mg 60687-0439-01 | American | 1 tablet | $0.083 | AB | Availability likely | — |
| Labetalol Hydrochloride 100 mg 23155-0723-01 | Heritage | 100 tablets | $0.083 | AB | Availability likely | — |
| Labetalol Hydrochloride 100 mg 68001-0381-00 | BluePoint | 100 tablets | $0.083 | AB | Availability likely | — |
| Labetalol hydrochloride 100 mg 00591-0605-01 | Actavis | 100 tablets | $0.084 | AB | Discontinued | — |
| Labetalol Hydrochloride 100 mg 42806-0327-01 | Epic | 100 tablets | — | AB | FDA listed | — |
| Labetalol Hydrochloride 100 mg 60760-0784-90 | St. | 90 tablets | — | AB | FDA listed | — |
| Labetalol hydrochloride 100 mg 71205-0095-30 | Proficient | 30 tablets | — | AB | FDA listed | — |
| Labetalol Hydrochloride 100 mg 50090-6741-00 | A-S | 60 tablets | — | AB | FDA listed | — |
| Labetalol Hydrochloride 100 mg 71209-0083-03 | Cadila | 60 tablets | — | AB | FDA listed | — |
| Labetalol Hydrochloride 100 mg 33342-0515-11 | Macleods | 100 tablets | — | AB | FDA listed | — |
| Labetalol Hydrochloride 100 mg 50090-7458-00 | A-S | 90 tablets | — | AB | FDA listed | — |
| Labetalol Hydrochloride 100 mg 60760-0991-90 | St. | 90 tablets | — | AB | FDA listed | — |
| Labetalol Hydrochloride 100 mg 67296-2156-01 | Redpharm | 15 tablets | — | AB | FDA listed | — |
| Labetalol Hydrochloride 100 mgthis 66112-0919-02 | Piramal | 100 tablets | — | — | FDA listed | — |
| Labetalol Hydrochloride 100 mg 51407-0614-01 | Golden | 100 tablets | — | AB | FDA listed | — |
| Labetalol Hydrochloride 100 mg 55154-0181-00 | Cardinal | 1 tablet | — | AB | FDA listed | — |
| Labetalol Hydrochloride 100 mg 70771-1163-01 | Zydus | 100 tablets | — | AB | FDA listed | — |
| Labetalol Hydrochloride 100 mg 71335-2475-01 | Bryant | 30 tablets | — | AB | FDA listed | — |
| Labetalol Hydrochloride 100 mg 70518-3499-00 | REMEDYREPACK | 30 tablets | — | AB | FDA listed | — |
| Labetalol Hydrochloride 100 mg 50090-7457-00 | A-S | 60 tablets | — | AB | FDA listed | — |
| Labetalol HCL 100 mg 71335-2145-01 | Bryant | 30 tablets | — | — | Discontinued | — |
| Labetalol Hydrochloride 100 mg 00615-8512-39 | NCS | 30 tablets | — | AB | FDA listed | — |
| Labetalol Hydrochloride 100 mg 51655-0322-25 | Northwind | 60 tablets | — | AB | FDA listed | — |
| Labetalol Hydrochloride 100 mg 82804-0289-90 | Proficient | 90 tablets | — | AB | FDA listed | — |
| Labetalol Hydrochloride 100 mg 70377-0060-11 | Biocon | 30 tablets | — | AB | FDA listed | — |
| Labetalol Hydrochloride 100 mg 55154-8192-00 | Cardinal | 1 tablet | — | AB | FDA listed | — |
| Labetalol Hydrochloride 100 mg 67046-1693-03 | Coupler | 30 tablets | — | AB | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA Orange Book · refreshed Nov 6, 2026
- CMS NADAC weekly file
Availability & generic status
FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available — see Therapeutic equivalents.
Where does this data come from?
- FDA Orange Book · refreshed Nov 6, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
🧪 Avoiding an ingredient? See Labetalol inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.
Where does this data come from?
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.- FDA label on DailyMed · label index refreshed Nov 21, 2026
- FDA openFDA NDC Directory · synced Nov 19, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from Piramal Pharma Limited labeler code 66112
- bempedoic acid and ezetimibe 180 mg; 10 mg Tablet, Film Coated NDC 66112-913-01
- Glipizide 5 mg Tablet NDC 66112-914-01
- Glipizide 10 mg Tablet NDC 66112-915-01
- Labetalol Hydrochloride 200 mg Aerosol NDC 66112-920-01
- Labetalol Hydrochloride 300 mg Aerosol NDC 66112-921-01
- Labetalol Hydrochloride 400 mg Aerosol NDC 66112-922-01
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- Drugs@FDA
Full FDA label FDA SPL
📄 FDA label ▾
No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.
Reported adverse events (FAERS)
Top reported reactions
Age at onset
Reporter sex
Serious outcomes
Where does this data come from?
About this NDC listing & data coverage
What "drug for further processing" means
FDA lists this package under the "drug for further processing" marketing category: Piramal Pharma Limited supplies it to other companies for further processing or repackaging (blister cards that are later repackaged or co-packaged are a common example). The units themselves are a finished dosage form — which is why pricing or Medicaid data can still appear — but this exact package code may not be the presentation a retail pharmacy dispenses.
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | — Not published for this NDC No photo available yet for this listing. |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |